US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,175.71

-20.7638-1.74%

Number of Gainers:1

Number of Losers:6

Number of Flat:- -

PE:- -

High:1,211.92

Open:1,195.10

Low:1,174.59

Close:1,196.47

Loading ...

The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron

Share Prices of These 4 US Growth Stocks Are at 52-Week Lows: Are They a Bargain?

The Smart Investor

Stocks to Watch Tuesday: GM, Porsche, Coca-Cola -- WSJ

Zacks.com featured highlights StoneCo, Carriage Services, Associated Banc-Corp and Pfizer

Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Pantera Lithium Advances Smackover Project Amid New Arkansas Legislation

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS

Notable companies reporting before tomorrow’s open

Pfizer (NYSE:PFE) Unveils Promising Preclinical Data On First-In-Class Oncology Drug

Simply Wall St.

HSBC cuts biotech stocks: Eli Lilly lowered to Reduce

Pfizer call volume above normal and directionally bullish

Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs

Eli Lily Shares Down 1.3% After HSBC Double Downgrades Rating to 'Reduce'

THOMSON REUTERS

Market Chatter: Fund Behind Novo Nordisk to Slow Down Investments Amid Tariff Turmoil

MT Newswires Live

4 Top Value Stocks to Invest in as US-Global Trade Talks Unfold

Viking Therapeutics Inc : Truist Securities Cuts Target Price to $75 From $95

THOMSON REUTERS

3 Dividend Stocks to Buy and Hold for the Next Decade

Down 36%, Is Moderna a Buy on the Dip?

Pfizer's Potential Invasive Bladder Cancer Treatment Meets Primary Endpoint

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4599/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1175.7089,"timestamp":1746820799999,"preClose":1196.4727,"halted":0,"volume":65719852,"delay":0,"changeRate":-0.017354,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-20.763794,"latestTime":"05-09 16:00:00 EDT","open":1195.0991,"high":1211.9174,"low":1174.5859,"amount":5821015703.3311,"amplitude":0.031201,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.288045,"peRate":31.06629,"turnoverRate":0.006213,"increases":1,"decrements":6,"flats":0,"marketCap":1262750061408,"floatMarketCap":1178055790176},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1211.9174,"amplitude":0.031201,"preClose":1196.4727,"low":1174.5859,"pbRate":"9.288045","latestPrice":1175.7089,"volume":65719852,"delay":0,"open":1195.0991,"prevYearClose":1305.0607,"prevWeekClose":1289.8245,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1289.8245,"twentyDayClose":1150.8268,"sixtyDayClose":1395.824,"secType":"PLATE","market":"US","turnoverRate":0.006213,"peRate":31.06629,"marketCap":1262750061408,"floatMarketCap":1178055790176,"timestamp":1746820799999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":1,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531273337","title":"The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron","url":"https://stock-news.laohu8.com/highlight/detail?id=2531273337","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531273337?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:32","pubTimestamp":1745922720,"startTime":"0","endTime":"0","summary":"Chicago, IL – April 29, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pfizer PFE, Eli Lilly LLY, Amgen AMGN, Biogen BIIB and Regeneron Pharmaceuticals REGN.The first-quarter earnings season for the drug and biotech sector will be in full swing this week, with many large drugmakers like Pfizer, Eli Lilly, Amgen, Biogen and Regeneron Pharmaceuticals, among others, due to announce results. Johnson & Johnson and Merck have already reported results, with both beating first-quarter estimates for earnings and sales. French drugmaker Sanofi came out with mixed first-quarter results as it beat estimates for earnings but missed the same for sales.Pfizer’s non-COVID operational revenues have been driving its top-line growth, backed by its key in-line products like Vyndaqel, Padcev and Eliquis, new la","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-103200684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1917777945.USD","LU0672654240.SGD","IE0004445239.USD","SG9999014898.SGD","LU1571399168.USD","LU2362541273.HKD","LU2362541513.USD","SGXZ99366536.SGD","LU1267930730.SGD","LU0238689110.USD","LU1280957306.USD","LU0321505439.SGD","LU1983299246.USD","IE00B19Z3581.USD","SG9999013999.USD","IE00B4R5TH58.HKD","PFE","SG9999014906.USD","LU2242646821.SGD","BK4534","LU0061475181.USD","SG9999015945.SGD","BIIB","LLY","LU1720051017.SGD","LU1035775433.USD","LU0079474960.USD","LU2089984988.USD","LU2362540622.SGD","IE0009355771.USD","BK4599","LU2361044949.HKD","LU0320765059.SGD","LU2106854487.HKD","REGN","SG9999003800.SGD","SG9999001440.SGD","LU0289739699.SGD","LU1127390331.HKD","IE00B19Z9Z06.USD","AMGN","LU2750360641.GBP","LU1061106388.HKD","LU2361044865.SGD","SG9999001176.USD","LU1814569148.SGD","LU0640476718.USD","SG9999001176.SGD","SG9999014914.USD","LU2264538146.SGD"],"gpt_icon":1},{"id":"2531920205","title":"Share Prices of These 4 US Growth Stocks Are at 52-Week Lows: Are They a Bargain?","url":"https://stock-news.laohu8.com/highlight/detail?id=2531920205","media":"The Smart Investor","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531920205?lang=en_us&edition=fundamental","pubTime":"2025-04-29 17:30","pubTimestamp":1745919000,"startTime":"0","endTime":"0","summary":"The Trump turmoil has pushed the share prices of these four stocks to their year lows. Could they be suitable for your portfolio?","market":"nz","thumbnail":"https://thesmartinvestor.com.sg/wp-content/uploads/2025/04/Boot-Barn-300x200.png","type":0,"news_type":0,"thumbnails":["https://thesmartinvestor.com.sg/wp-content/uploads/2025/04/Boot-Barn-300x200.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thesmartinvestor.com.sg/share-prices-of-these-4-us-growth-stocks-are-at-52-week-lows-are-they-a-bargain/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thesmartinvestor_highlight","symbols":["BOOT","IE00BZ1G4Q59.USD","NVO","LU0444973449.USD","LU1059921491.USD","LU1093756325.SGD","GPN","LU0476273544.USD","LU0957808578.USD","LU0154236417.USD","LU1559883803.SGD","LU0106831901.USD","LU1815336760.USD","LU1642822529.SGD","LU1861220207.SGD","LU1923622291.USD","LU0211331839.USD","BK4585","BK4535","LU2125909916.SGD","BK4094","YELP","BK4227","LU0208291251.USD","LU0566484027.USD","IE00BKVL7J92.USD","LU0070302665.USD","BK4106","BK4532","BK4599","LU1093756168.USD","LU1668664300.SGD","LU1791807156.HKD","LU2360107671.USD","LU0444971666.USD","LU2125909759.SGD","BK4551","BK4007","LU1861217088.USD","BK4588","LU0320765489.SGD","BK4077"],"gpt_icon":1},{"id":"2531203099","title":"Stocks to Watch Tuesday: GM, Porsche, Coca-Cola -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2531203099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531203099?lang=en_us&edition=fundamental","pubTime":"2025-04-29 17:20","pubTimestamp":1745918400,"startTime":"0","endTime":"0","summary":"General Motors : The automaker's quarterly earnings, due Tuesday, should shed some light on the potential hit from tariffs. Late Monday, The Wall Street Journal reported that car manufacturers paying President Trump's auto levies will likely be exempt from other duties, such as on steel and aluminum. GM shares edged higher in premarket trading.Porsche : The German luxury-car brand slashed its financial guidance, as the prospective hit from tariffs adds to its challenges. Shares dropped more than 4%. Volvo Car  also withdrew its financial outlook, knocking its shares in Stockholm.Stellantis : Shares in the Jeep and Ram maker rose in Europe. Unlike Porsche, Stellantis has U.S. factories, meaning it would benefit from Trump's potential softening of auto tariffs.Rheinmetall : Shares in the German defense company rose 6% after it posted better-than-expected earnings. The company has been a major beneficiary of European rearmament.American Airlines ; JetBlue Airways : American sued JetBlue t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130102774.USD","IE00BLSP4239.USD","BK4574","LU1066053197.SGD","BK4547","BK4581","LU1064927863.SGD","LU1861217088.USD","IE00BQXX3F31.USD","LU2089284900.SGD","UPS","LU0070302665.USD","BK4516","LU2360107671.USD","GM","LU1670710588.SGD","LU0477156797.USD","LU0949170772.SGD","BK4592","LU1861220207.SGD","LU2264538146.SGD","LU1430594728.SGD","BK4599","JBLU","LU1868836757.USD","LU2125154935.USD","SG9999013999.USD","LU0225284248.USD","LU0320765646.SGD","BK4559","LU0072461881.USD","BK4532","LU2506952170.USD","LU0320765489.SGD","BK4566","BK4561","LU1670711123.USD","LU0985481810.HKD","BK4500","LU1883839398.USD","IE00BJJMRY28.SGD","IE00BDGV0183.EUR","STLA","SGXZ57979304.SGD","LU1718418525.SGD","LU0175139822.USD"],"gpt_icon":1},{"id":"2531200697","title":"Zacks.com featured highlights StoneCo, Carriage Services, Associated Banc-Corp and Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2531200697","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531200697?lang=en_us&edition=fundamental","pubTime":"2025-04-29 17:08","pubTimestamp":1745917680,"startTime":"0","endTime":"0","summary":"Chicago, IL – April 29, 2025 – Stocks in this week’s article are StoneCo Ltd. STNE, Carriage Services, Inc. CSV, Associated Banc-Corp ASB and Pfizer Inc. PFE.4 Top Value Stocks to Invest in as U.S. Trade Talks Unfold. Investor sentiment was buoyed by strong quarterly earnings reports and speculation that current tariff policies might see revisions. Earlier this month, President Trump announced a 90-day hiatus on broad \"reciprocal\" tariffs, initiating negotiations with several countries.When evaluating value stocks, one of the most effective valuation metrics is the Price to Cash Flow  ratio. Companies like StoneCo Ltd., Carriage Services, Inc., Associated Banc-Corp and Pfizer Inc. boast a low P/CF ratio. The P/CF ratio evaluates the market price of a stock relative to the amount of cash flow that the company is generating on a per-share basis — the lower the number, the better.An investment decision based solely on the P/CF metric may not yield the desired results. To identify stocks t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-com-featured-highlights-stoneco-090800568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","BK4211","BK4559","IE00B19Z3581.USD","BK4588","LU0456855351.SGD","ASB","LU0306806265.USD","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","CSV","BK4192","LU0321505439.SGD","BK4566","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","PFE","SG9999001176.USD","IE00BBT3K403.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","BK4535","LU0058720904.USD","BK4599","BK4585","IE00BLSP4452.SGD","LU0289739699.SGD","LU1878469433.USD","STNE","SG9999002232.USD","BK4227","BK4106","LU0306807586.USD","BK4568","BK4533","LU0321505868.SGD","LU1883839398.USD","BK4007","LU1057294990.SGD","LU1066053197.SGD"],"gpt_icon":1},{"id":"2531221338","title":"Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2531221338","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531221338?lang=en_us&edition=fundamental","pubTime":"2025-04-29 14:45","pubTimestamp":1745909132,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/45059221/pfizer-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LU0106831901.USD","LU2089284900.SGD","SG9999003800.SGD","BK4535","LU0320765646.SGD","LU0225771236.USD","LU0006306889.USD","BK4588","LU2111349929.HKD","BK4504","BK4599","IE00BZ1G4Q59.USD","IE0002270589.USD","LU1720051108.HKD","BK4196","PFE","LU0321505439.SGD","LU1668664300.SGD","LU1732799900.SGD","LU2028103732.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","IE00B19Z3581.USD","LU1894683348.USD","LU1548497426.USD","LU0795875086.SGD","LU0170899867.USD","LU0158827781.USD","LU1162221912.USD","LU1883839398.USD","LU0985481810.HKD","SG9999001176.USD","SGXZ57979304.SGD","LU2133065610.SGD","IE00BKVL7J92.USD","GH","LU0321505868.SGD","SG9999002224.SGD","LU1074936037.SGD","BK4533","LU0106261372.USD","LU0306807586.USD","SG9999001176.SGD","LU1732800096.USD","LU2357305700.SGD","BK4007","BK4534","IE00BLSP4239.USD","LU1066053197.SGD"],"gpt_icon":1},{"id":"2531294392","title":"Pantera Lithium Advances Smackover Project Amid New Arkansas Legislation","url":"https://stock-news.laohu8.com/highlight/detail?id=2531294392","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531294392?lang=en_us&edition=fundamental","pubTime":"2025-04-29 14:36","pubTimestamp":1745908600,"startTime":"0","endTime":"0","summary":"Pantera Minerals Ltd. ( ($AU:PFE) ) has issued an announcement. Pantera Lithium Limited has completed additional subsurface modeling for its Smacko...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pantera-lithium-advances-smackover-project-amid-new-arkansas-legislation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pantera-lithium-advances-smackover-project-amid-new-arkansas-legislation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0456855351.SGD","BK4599","BK4534","BK4581","BK4592","LU0234572021.USD","LU1057294990.SGD","BK4585","BK4533","IE00BLSP4239.USD","SG9999002232.USD","LU1883839398.USD","SG9999013999.USD","LU1066051498.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0306807586.USD","LU0058720904.USD","LU0225284248.USD","LU0321505868.SGD","SG9999011175.SGD","LU0225771236.USD","IE0002270589.USD","LU1894683264.USD","IE00BLSP4452.SGD","BK4568","BK4007","IE00B19Z3581.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU0306806265.USD","LU0122379950.USD","LU1066053197.SGD","SG9999003800.SGD","SG9999001176.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683348.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0321505439.SGD","SG9999002224.SGD","LU0985481810.HKD","BK4588","LU0170899867.USD","BK4550"],"gpt_icon":0},{"id":"2531266914","title":"GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531266914","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531266914?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:10","pubTimestamp":1745871000,"startTime":"0","endTime":"0","summary":"Lille , Cambridge , Zurich , April 28, 2025 - GENFIT , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that Ipsen will be presenting data from its late-breaking abstract on elafibranor, highlighting favorable safety profile and significant efficacy in Primary Sclerosing Cholangitis , at the European Association for the Study of the Liver  on May 10, 2025 at 11.15 CET.Pascal Prigent, CEO of GENFIT, commented: “We continue to be very pleased with Ipsen’s commitment to developing elafibranor, and the results from the ELMWOOD Phase 2 trial further reinforce our belief in elafibranor’s potential to address serious liver diseases.”ABOUT PSCPSC is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, which can lead to liver damage and eventually liver failure. The exact cause of PSC is unknown, but it is often associated with other autoimmune conditions, such as inflam","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-positive-breaking-phase-2-201000577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1878469433.USD","LU0979878070.USD","GGT","BK4183","LU1242518931.SGD","LU0053671581.USD","LU0566484027.USD","CCA","ALT","LU1242518857.USD","PBC","ELF","BK4139","GNFT","BK4201","PSC","USA","GNFTF","EC","BK4585","BK4599","LU1559883803.SGD","BK4588"],"gpt_icon":0},{"id":"2531298336","title":"AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS","url":"https://stock-news.laohu8.com/highlight/detail?id=2531298336","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531298336?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:01","pubTimestamp":1745870460,"startTime":"0","endTime":"0","summary":"THOUSAND OAKS, Calif., April 28, 2025 /PRNewswire/ -- Amgen  today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. Th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/amgen-announces-webcast-2025-first-200100621.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-announces-webcast-2025-first-200100621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4566","AMGN","BK4534","BK4139","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU1061106388.HKD","LU0868494617.USD","LU0058720904.USD","BK4585","LU2112291526.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU2242652126.USD","IE0002141913.USD","LU1571399168.USD","BK4599","IE00B2B36J28.USD","LU0122379950.USD","LU0289739699.SGD","BK4588","LU0320765992.SGD","IE0009355771.USD","BK4533","SG9999001440.SGD","LU2089984988.USD","LU1023059063.AUD","LU1983299246.USD","BK4581","LU2242646821.SGD"],"gpt_icon":0},{"id":"2531259033","title":"Notable companies reporting before tomorrow’s open","url":"https://stock-news.laohu8.com/highlight/detail?id=2531259033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531259033?lang=en_us&edition=fundamental","pubTime":"2025-04-29 02:20","pubTimestamp":1745864424,"startTime":"0","endTime":"0","summary":"Notable companies reporting before tomorrow’s open, with earnings consensus, include Coca-Cola (KO), consensus 72c… Pfizer (PFE), consensus 69c… Ho...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/notable-companies-reporting-before-tomorrows-open-537?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/notable-companies-reporting-before-tomorrows-open-537?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2347655156.SGD","SG9999011175.SGD","SG9999013999.USD","LU2133065610.SGD","LU1868836591.USD","SG9999003800.SGD","SG9999014575.USD","LU1883839398.USD","SGXZ23171101.USD","LU2506951875.HKD","LU0265550946.USD","LU0289739699.SGD","LU0234572021.USD","LU0738911758.USD","BK4532","LU0306807586.USD","IE00BLSP4239.USD","LU1023059063.AUD","KO","PFE","LU0661504455.SGD","LU0061475181.USD","SG9999001176.SGD","LU0950375773.USD","BK4559","LU0545039389.USD","BK4177","BK4599","SG9999015358.SGD","BK4533","LU0823417737.USD","LU0122379950.USD","IE00B42XCP33.USD","LU1162221912.USD","LU2237443895.HKD","LU1732799900.SGD","IE00BGHQF631.EUR","IE00BDGV0183.EUR","LU1732800096.USD","LU1670711040.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","SG9999014559.SGD","LU1718418525.SGD","BK4007","IE00BLSP4452.SGD","LU0868494617.USD","LU1066051498.USD","LU2237443549.SGD","BK4581"],"gpt_icon":0},{"id":"2531425632","title":"Pfizer (NYSE:PFE) Unveils Promising Preclinical Data On First-In-Class Oncology Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2531425632","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531425632?lang=en_us&edition=fundamental","pubTime":"2025-04-29 01:37","pubTimestamp":1745861844,"startTime":"0","endTime":"0","summary":"Pfizer received heightened attention as it showcased preclinical data on its groundbreaking PF-08052666 compound at the AACR Annual Meeting. Despite the company's stock moving 4% last week, the broader market saw a 7% rise, which indicates Pfizer's performance wasn't significantly different from overall trends. The release of positive Phase 3 trial results for sasanlimab and the partnership with Guardant Health may have added weight to Pfizer's position, as did the announcement of its consistent dividend payout. These developments came amid a volatile market environment, influenced by various factors, including major corporate earnings and economic data releases.We've identified 3 possible red flags for Pfizer  that you should be aware of.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-nyse-pfe-unveils-promising-173724581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0321505868.SGD","IE00B19Z3B42.SGD","BK4550","BK4581","LU0225771236.USD","LU0225284248.USD","BK4568","LU0058720904.USD","LU0170899867.USD","SGXZ57979304.SGD","BK4599","LU1057294990.SGD","IE00B19Z3581.USD","LU0321505439.SGD","LU1066053197.SGD","LU0306807586.USD","IE000M9KFDE8.USD","LU1883839398.USD","LU1894683264.USD","LU0456855351.SGD","SG9999002232.USD","BK4585","LU1894683348.USD","SG9999003800.SGD","SG9999001176.SGD","LU0985481810.HKD","LU0289739699.SGD","BK4534","BK4592","PFE","SG9999002224.SGD","LU0868494617.USD","BK4533","SG9999001176.USD","LU0306806265.USD","IE0002270589.USD","IE00BLSP4452.SGD","NYSE","BK4007","BK4588","SG9999011175.SGD","LU0234572021.USD","IE00BBT3K403.USD","LU0122379950.USD","LU1023059063.AUD","IE00BLSP4239.USD","LU1066051498.USD","SG9999013999.USD"],"gpt_icon":1},{"id":"2530397642","title":"HSBC cuts biotech stocks: Eli Lilly lowered to Reduce","url":"https://stock-news.laohu8.com/highlight/detail?id=2530397642","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530397642?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:37","pubTimestamp":1745854673,"startTime":"0","endTime":"0","summary":"Investing.com --HSBC downgraded several major biotech names this week, citing macroeconomic sensitivities, tariff risks, and growing pressure from regulatory changes. Most notably, the bank downgraded Lilly to Reduce from Buy.The firm said the risk-reward for Eli Lilly  is \"not attractive,\" especially given uncertainties surrounding the future growth of its obesity drug franchise.HSBC noted, \"We are not certain that is the case for Lilly\" regarding continued script momentum as market dynamics shift.Broader concerns also weighed on HSBC’s view of the sector. The analysts pointed out that \"the confluence of first-time US tariffs risks combined with a large patent cliff and Part D/IRA headwind might create some pressure on earnings this time.\". Their proprietary analysis found that \"innovative pharma could face earnings headwinds of roughly c6-14% if a 25% US tariff were applied.\". HSBC also flagged risks from changes to Medicare’s Part D program, warning, \"Part D earnings risk in H2’25 i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hsbc-cuts-biotech-stocks-eli-153753390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BJJMRZ35.SGD","LU1244550494.USD","HSBC","LU2592432038.USD","SG9999015952.SGD","LU0109391861.USD","IE00BFXG1179.USD","LU1032955483.USD","LU1244550221.USD","LU1064131342.USD","IE00BJLML261.HKD","SGXZ31699556.SGD","LU1061106388.HKD","LU0820561818.USD","LU1093756168.USD","LU2471134523.USD","IE00BK4W5M84.HKD","LU2491049909.HKD","LU0096364046.USD","LU0795875086.SGD","IE0002141913.USD","LU1894683348.USD","BK4599","JNJ","LU0672654240.SGD","IE00B3PB1722.GBP","LU1804176565.USD","BIIB","IE0009355771.USD","LU0122379950.USD","LU1057294990.SGD","LU2750360997.AUD","LU0345770993.USD","IE00BVYPNV92.GBP","SG9999014898.SGD","IE00BDGV0183.EUR","LLY","LU2471134879.HKD","BK4534","IE0034235303.USD","IE00B19Z3581.USD","LU1093756325.SGD","LU2106854487.HKD","LU2129689605.HKD","LU2129689514.USD","LU1917777945.USD","LU1035775433.USD","LU0345769128.USD","SNY","LU2236285917.USD"],"gpt_icon":1},{"id":"2530239117","title":"Pfizer call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2530239117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530239117?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:25","pubTimestamp":1745853906,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Pfizer (PFE) with 45,740 calls trading, 1.0x expected, and implied vol increasing over 1 point to 30.86%. 5/2 weekl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-call-volume-above-normal-and-directionally-bullish-15?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-call-volume-above-normal-and-directionally-bullish-15?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BLSP4239.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU1066053197.SGD","BK4534","LU1066051498.USD","SG9999001176.USD","LU0122379950.USD","BK4581","LU1894683348.USD","LU1894683264.USD","LU0321505868.SGD","BK4592","IE00BBT3K403.USD","BK4550","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4599","LU0306806265.USD","SG9999002232.USD","BK4585","SG9999013999.USD","LU0225284248.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999003800.SGD","SG9999011175.SGD","BK4588","LU1023059063.AUD","LU0306807586.USD","LU0456855351.SGD","BK4533","IE00BLSP4452.SGD","LU0170899867.USD","PFE","LU0321505439.SGD","LU0234572021.USD","BK4007","LU0058720904.USD","LU0868494617.USD","LU0985481810.HKD","IE000M9KFDE8.USD","LU1883839398.USD","LU0225771236.USD","IE0002270589.USD","SGXZ57979304.SGD","BK4568"],"gpt_icon":0},{"id":"2530605236","title":"Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2530605236","media":"GuruFocus.com","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530605236?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:20","pubTimestamp":1745853637,"startTime":"0","endTime":"0","summary":"April 28 - Eli Lilly , Pfizer , Amgen , and possibly other pharma companies could lose up to $51 billion annually if U.S. President Donald Trump's proposed 25% tariffs on pharmaceuticals move forward.GuruFocus has detected 6 Warning Signs with AMGN.Research from the Pharmaceutical Research and Manufacturers of America  cited by Reuters said the costs could ripple to consumers, raising U.S. drug prices by nearly 13%. In 2023, the U.S. imported $203 billion in pharmaceutical products, with about 73% sourced from Europe, highlighting the country's dependence on foreign medicines.Although the Commerce Department exempted pharma from reciprocal tariffs, it has launched a separate sector investigation. A 21-day public comment window is now open for feedback on the proposed levies. Drugmakers are urging the administration to phase in tariffs gradually or exempt them altogether, citing that about 25% of U.S. pharmaceutical output, worth $101 billion, was exported last year.Analysts warn that i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lilly-pfizer-risk-billions-152037442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1057294990.SGD","IE0002141913.USD","SG9999003800.SGD","BK4581","SG9999018865.SGD","LU2357305700.SGD","IE000M9KFDE8.USD","LU2471134523.USD","LU0321505868.SGD","LU1291159041.SGD","LU2552382058.USD","LU0122379950.USD","SG9999001176.USD","BK4568","LU0096364046.USD","LU2106854487.HKD","LU1064131342.USD","LU2237443549.SGD","BK4550","LU1988902786.USD","LU0114720955.EUR","SG9999014914.USD","LU0823416689.USD","SG9999014898.SGD","SGXZ81514606.USD","LU0306807586.USD","BK4592","LU2491049909.HKD","PFE","LU0079474960.USD","IE00BJJMRZ35.SGD","LU2491050071.SGD","LU0471298777.SGD","AMGN","LU1983299246.USD","LU2242646821.SGD","LU2471134879.HKD","LU1868836591.USD","LU2211815571.USD","BK4599","LU2552382215.SGD","LU0385154629.USD","LLY","LU1548497426.USD","LU1069344957.HKD","IE00B4R5TH58.HKD","LU0943347566.SGD","LU1814569148.SGD","LU1280957306.USD","LU0417517546.SGD"],"gpt_icon":1},{"id":"2530285505","title":"Eli Lily Shares Down 1.3% After HSBC Double Downgrades Rating to 'Reduce'","url":"https://stock-news.laohu8.com/highlight/detail?id=2530285505","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530285505?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:31","pubTimestamp":1745847106,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R6197:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1280957306.USD","LU1917777945.USD","IE00BK4W5L77.USD","LU2357305700.SGD","LU1023059063.AUD","LU0456855351.SGD","LU2602419157.SGD","BK4585","LU2023250504.SGD","LU0417517546.SGD","LU1064131342.USD","IE00BFTCPJ56.SGD","LU1623119135.USD","LU2106854487.HKD","LU2237443978.SGD","SG9999001176.SGD","BK4533","SGXZ81514606.USD","LU0320765059.SGD","LLY","LU0006306889.USD","LU2211815571.USD","BK4599","LU2491049909.HKD","LU0820561909.HKD","LU1232071149.USD","LU1366192091.USD","LU2491050154.USD","LU0094547139.USD","IE00BJJMRZ35.SGD","LU0689472784.USD","LU2471134952.CNY","LU0943347566.SGD","SGXZ99366536.SGD","LU0672654240.SGD","LU1267930730.SGD","LU1127390331.HKD","LU0640476718.USD","LU2264538146.SGD","LU2750360641.GBP","LU0114720955.EUR","SGXZ31699556.SGD","LU0109391861.USD","LU0203202063.USD","LU0882574055.USD","LU0256863811.USD","LU0198837287.USD","SG9999014898.SGD","SG9999015945.SGD","LU2471134879.HKD"],"gpt_icon":0},{"id":"2530404985","title":"Market Chatter: Fund Behind Novo Nordisk to Slow Down Investments Amid Tariff Turmoil","url":"https://stock-news.laohu8.com/highlight/detail?id=2530404985","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530404985?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:39","pubTimestamp":1745843941,"startTime":"0","endTime":"0","summary":"Novo Holdings, the $160 billion fund behind Novo Nordisk , will slow down its investment activities until there is more clarity on economic growth prospects, Bloomberg reported Monday, citing Novo Holdings chief executive officer Kasim Kutay as saying in an interview.Novo Holdings' plans to exit \"some assets\" will most likely have to be postponed until later this year or even next year, the report said, citing Kutay.\"I mean, who's going to IPO an asset in this environment?Unless you have to, it's probably not advisable,\" Kutay said in the interview, Bloomberg reported.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","LU1093756168.USD","LU0154236417.USD","BK7104","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","BK4599","BK4007","BK4532","IE00BKVL7J92.USD","BK4588"],"gpt_icon":1},{"id":"2530786282","title":"4 Top Value Stocks to Invest in as US-Global Trade Talks Unfold","url":"https://stock-news.laohu8.com/highlight/detail?id=2530786282","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530786282?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:17","pubTimestamp":1745842620,"startTime":"0","endTime":"0","summary":"What’s the Best Value Investing Strategy?An investment decision based solely on the P/CF metric may not yield the desired results. To identify stocks that are trading at a discount, you should expand your search criteria and also consider the price-to-book ratio, price-to-earnings ratio and price-to-sales ratio. Adding a favorable Zacks Rank and a Value Score of A or B to your search criteria should lead to even better results as these eliminate the chance of falling into a value trap.Here are the parameters for selecting true-value stocks:P/CF less than or equal t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4-top-value-stocks-invest-121700241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","LU1878469433.USD","BK4568","LU1894683264.USD","SGXZ57979304.SGD","BK4581","BK4566","IE00BBT3K403.USD","LU1057294990.SGD","SG9999001176.USD","IE0002270589.USD","LU0225771236.USD","STNE","LU0868494617.USD","BK4535","SG9999002224.SGD","SG9999013999.USD","LU0170899867.USD","BK4559","BK4192","BK4585","LU0234572021.USD","BK4533","SG9999011175.SGD","LU0306807586.USD","BK4227","IE00BLSP4239.USD","PFE","LU1023059063.AUD","ASB","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","CSV","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2530403257","title":"Viking Therapeutics Inc : Truist Securities Cuts Target Price to $75 From $95","url":"https://stock-news.laohu8.com/highlight/detail?id=2530403257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530403257?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:01","pubTimestamp":1745841670,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R61ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4599","VKTX","BK4585","BK4588"],"gpt_icon":0},{"id":"2530754408","title":"3 Dividend Stocks to Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2530754408","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530754408?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:47","pubTimestamp":1745840820,"startTime":"0","endTime":"0","summary":"Abbott Laboratories is a diversified dividend stock with a growing payout.AbbVie is a reliable dividend payer to hold for the long term.Pfizer offers an ultra-high dividend yield and a growth story that's better than it might appear at first glance.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/28/3-dividend-stocks-to-buy-and-hold-for-the-next-dec/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1023059063.AUD","LU0058720904.USD","BK4533","LU0985481810.HKD","LU2089984988.USD","PFE","IE0002141913.USD","LU2112291526.USD","IE00B19Z3B42.SGD","BK4550","LU0122379950.USD","LU0321505868.SGD","BK4588","BK4082","IE00BBT3K403.USD","LU0321505439.SGD","LU0234572021.USD","SG9999001176.USD","SG9999004303.SGD","BK4585","BK4592","BK4568","IE00B4R5TH58.HKD","ABT","LU1066053197.SGD","LU1721429402.USD","LU1066051498.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1883839398.USD","LU2133065610.SGD","BK4566","LU1894683264.USD","BK4534","IE000M9KFDE8.USD","BK4581","SG9999011175.SGD","BK4599","LU0170899867.USD","IE00B19Z3581.USD","LU0225284248.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU1721429741.USD","SGXZ23171101.USD","LU1691799644.USD","IE0002270589.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2530766084","title":"Down 36%, Is Moderna a Buy on the Dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530766084","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530766084?lang=en_us&edition=fundamental","pubTime":"2025-04-28 18:21","pubTimestamp":1745835660,"startTime":"0","endTime":"0","summary":"It wasn't so long ago that the company was a major star in the biotech world.This was on the basis of one product, however, and demand for it is declining steeply.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/28/down-36-is-moderna-a-buy-on-the-dip/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4568","LU0321505439.SGD","SG9999001176.USD","IE00BBT3K403.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU0122379950.USD","BK4592","LU1894683264.USD","LU0321505868.SGD","BK4533","BK4588","LU0225771236.USD","SG9999013999.USD","SG9999002224.SGD","LU0456855351.SGD","LU1066053197.SGD","LU0306806265.USD","SG9999003800.SGD","LU0170899867.USD","BK4581","LU1894683348.USD","LU1883839398.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","BK4585","SGXZ57979304.SGD","LU1066051498.USD","BK4007","LU0225284248.USD","IE00BLSP4239.USD","LU0058720904.USD","IE0002270589.USD","BK4599","LU0868494617.USD","LU1057294990.SGD","LU0306807586.USD","LU1023059063.AUD","SG9999001176.SGD","LU0234572021.USD","SG9999002232.USD","BK4534","LU0985481810.HKD","IE000M9KFDE8.USD","BK4550"],"gpt_icon":1},{"id":"2530242702","title":"Pfizer's Potential Invasive Bladder Cancer Treatment Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2530242702","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530242702?lang=en_us&edition=fundamental","pubTime":"2025-04-28 17:52","pubTimestamp":1745833948,"startTime":"0","endTime":"0","summary":"Pfizer  said Saturday that its investigational drug sasanlimab in combination with standard of care Bacillus Calmette-Guerin as induction and maintenance therapy in patients with high-risk non-muscle invasive bladder cancer met its primary endpoint of event-free survival in a phase 3 trial.The trial showed a 32% reduction in the risk of disease-related events with the sasanlimab combination regimen as compared with the standard of care treatment alone, the pharmaceutircal giant said.The probability of being event-free at 36 months was 82.1% with sasanlimab in combination with BCG and 74.8% with BCG alone, the company said.Sasanlimab in combination with induction-only BCG failed to meet a secondary endpoint of prolongation of event-free survival compared with BCG alone as an induction and maintenance therapy, the company said.Pfizer said it has shared study data with health authorities worldwide to support potential regulatory filings.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BBT3K403.USD","LU0306807586.USD","PFE","LU1066053197.SGD","LU1894683264.USD","LU1066051498.USD","SG9999013999.USD","IE00BLSP4452.SGD","BK4568","IE000M9KFDE8.USD","BK4599","SG9999002232.USD","LU0321505439.SGD","BK4534","LU0170899867.USD","LU0321505868.SGD","LU0225771236.USD","LU1883839398.USD","LU0306806265.USD","IE0002270589.USD","SG9999001176.USD","LU0225284248.USD","BK4592","BK4007","BK4533","IE00B19Z3B42.SGD","LU1023059063.AUD","SG9999011175.SGD","LU1057294990.SGD","LU0868494617.USD","BK4588","SG9999003800.SGD","BK4585","IE00BLSP4239.USD","LU0122379950.USD","LU1894683348.USD","BK4581","BK7095","SGXZ57979304.SGD","LU0456855351.SGD","LU0234572021.USD","PFE.AU","LU0058720904.USD","LU0289739699.SGD","SG9999002224.SGD","SG9999001176.SGD","LU0985481810.HKD","BK4550","IE00B19Z3581.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":198,"code":"91000000","status":"200"}]}}